|473.06||-6.01 / -1.25%|
As of 3:59pm ET
|471.19||-1.87 / -0.40%|
The 21 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 595.00, with a high estimate of 700.00 and a low estimate of 500.00. The median estimate represents a +25.78% increase from the last price of 473.06.
The current consensus among 23 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals. This rating has held steady since October, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.